Indication

Adenoid Cystic Carcinoma of the Head and Neck

1 clinical trial

2 products

Clinical trial

A Phase Ib Study of OBT076 or OBT076 Followed by Balstilimab in Patients With Recurrent or Metastatic (R/M) Adenoid Cystic Carcinoma (AdCC) of the Head and Neck (H&N)

Status: Recruiting, Estimated PCD: 2026-09-01

Product

Product